{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T01:52:43Z","timestamp":1789955563919,"version":"4.0.1"},"reference-count":92,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.ejmech.2018.08.012","type":"journal-article","created":{"date-parts":[[2018,8,6]],"date-time":"2018-08-06T12:23:20Z","timestamp":1533558200000},"page":"339-367","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"special_numbering":"C","title":["An update on small molecule strategies targeting leishmaniasis"],"prefix":"10.1016","volume":"157","author":[{"given":"Swati","family":"Kapil","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pankaj Kumar","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1174-1125","authenticated-orcid":false,"given":"Om","family":"Silakari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.08.012_bib1","series-title":"Leishmaniasis","author":"WHO Factsheet","year":"2018"},{"key":"10.1016\/j.ejmech.2018.08.012_bib2","first-page":"175","article-title":"Drug discovery and development for neglected diseases: the DNDi model","volume":"5","author":"Chatelain","year":"2011","journal-title":"Drug Design, Development and Therapy"},{"issue":"1","key":"10.1016\/j.ejmech.2018.08.012_bib3","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/S0035-9203(38)90097-5","article-title":"Early discoveries regarding the parasite of oriental sore","volume":"32","author":"Hoare","year":"1938","journal-title":"Trans. R. Soc. Trop. Med. Hyg."},{"key":"10.1016\/j.ejmech.2018.08.012_bib4","series-title":"Leishmaniasis and HIV Coinfection","author":"WHO","year":"2017"},{"issue":"11","key":"10.1016\/j.ejmech.2018.08.012_bib5","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1016\/j.intimp.2011.08.002","article-title":"Immunomodulation by chemotherapeutic agents against Leishmaniasis","volume":"11","author":"Saha","year":"2011","journal-title":"Int. Immunopharm."},{"issue":"1","key":"10.1016\/j.ejmech.2018.08.012_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s12639-010-0006-3","article-title":"Drug targets in leishmania","volume":"34","author":"Chawla","year":"2010","journal-title":"J.\u00a0Parasit. Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2018.08.012_bib7","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.pt.2007.02.004","article-title":"Metabolism of Leishmania: proven and predicted","volume":"23","author":"Opperdoes","year":"2007","journal-title":"Trends Parasitol."},{"issue":"4","key":"10.1016\/j.ejmech.2018.08.012_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1128\/mr.52.4.412-432.1988","article-title":"Biochemistry of the leishmania species","volume":"52","author":"Glew","year":"1988","journal-title":"Microbiol. Rev."},{"issue":"1","key":"10.1016\/j.ejmech.2018.08.012_bib9","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1475-9292-2-14","article-title":"Physiological consequences of drug resistance in Leishmania and their relevance for chemotherapy","volume":"2","author":"Ponte-Sucre","year":"2003","journal-title":"Kinetoplastid Biology and Disease"},{"key":"10.1016\/j.ejmech.2018.08.012_bib10","series-title":"Drug Resistance in Leishmania","first-page":"1","author":"L\u00e9gar\u00e9","year":"2014"},{"issue":"3","key":"10.1016\/j.ejmech.2018.08.012_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pt.2016.11.003","article-title":"Exploiting knowledge on Leishmania drug resistance to support the quest for new drugs","volume":"33","author":"Hefnawy","year":"2017","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.ejmech.2018.08.012_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1051\/parasite\/1990651037","article-title":"The life-cycle of Leishmania in the sandfly with special reference to the form infective to the vertebrate host","volume":"65","author":"Killick-Kendrick","year":"1990","journal-title":"Ann. Parasitol. Hum. Comp."},{"issue":"1","key":"10.1016\/j.ejmech.2018.08.012_bib13","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2217\/fmb.14.103","article-title":"Leishmania and the macrophage: a multifaceted interaction","volume":"10","author":"Podinovskaia","year":"2015","journal-title":"Future Microbiology"},{"key":"10.1016\/j.ejmech.2018.08.012_bib14","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.actatropica.2015.12.016","article-title":"Visceral leishmaniasis: revisiting current treatments and approaches for future discoveries","volume":"155","author":"No","year":"2016","journal-title":"Acta Tropica"},{"issue":"4","key":"10.1016\/j.ejmech.2018.08.012_bib15","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1128\/CMR.15.4.595-612.2002","article-title":"History of human parasitology","volume":"15","author":"Cox","year":"2002","journal-title":"Clin. Microbiol. Rev."},{"issue":"8","key":"10.1016\/j.ejmech.2018.08.012_bib16","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/j.drudis.2015.04.006","article-title":"Potential therapeutic targets and the role of technology in developing novel antileishmanial drugs","volume":"20","author":"Rajasekaran","year":"2015","journal-title":"Drug Discovery Today"},{"issue":"10","key":"10.1016\/j.ejmech.2018.08.012_bib17","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.4155\/fmc.12.68","article-title":"Dihydrofolate reductase as a therapeutic target for infectious diseases: opportunities and challenges","volume":"4","author":"Sharma","year":"2012","journal-title":"Future Medicinal Chemistry"},{"issue":"29","key":"10.1016\/j.ejmech.2018.08.012_bib18","doi-asserted-by":"crossref","first-page":"12324","DOI":"10.1074\/jbc.M116.772624","article-title":"The iron-dependent mitochondrial superoxide dismutase SODA promotes Leishmania virulence","volume":"292","author":"Mittra","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2018.08.012_bib19","series-title":"Molecular Docking and Molecular Dynamics Simulation Study of Inositol Phosphorylceramide Synthase\u2013inhibitor Complex in Leishmaniasis: Insight into the Structure Based Drug Design","first-page":"5","author":"Mandlik","year":"2016"},{"key":"10.1016\/j.ejmech.2018.08.012_bib20","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.genrep.2016.05.002","article-title":"Integrative approaches for identification of novel ISCL inhibitors in Leishmaniasis: a computational insight into the structure","volume":"4","author":"Mandlik","year":"2016","journal-title":"Gene Rep."},{"issue":"8","key":"10.1016\/j.ejmech.2018.08.012_bib21","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1021\/acs.jpcb.6b11948","article-title":"Interaction of KMP-11 with phospholipid membranes and its implications in leishmaniasis: effects of single tryptophan mutations and cholesterol","volume":"121","author":"Sannigrahi","year":"2017","journal-title":"J.\u00a0Phys. Chem. B"},{"issue":"536","key":"10.1016\/j.ejmech.2018.08.012_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1098\/rspb.1908.0001","article-title":"Further results of the experimental treatment of trypanosomiasis in rats; being a progress report of a committee of the Royal Society","volume":"80","author":"HG Plimmer","year":"1908","journal-title":"Proc. Roy. Soc. Lond. B"},{"key":"10.1016\/j.ejmech.2018.08.012_bib23","doi-asserted-by":"crossref","DOI":"10.4061\/2011\/571242","article-title":"Use of antimony in the treatment of leishmaniasis: current status and future directions","volume":"2011","author":"Haldar","year":"2011","journal-title":"Mol. Biol. Int."},{"issue":"1\u20132","key":"10.1016\/j.ejmech.2018.08.012_bib24","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.molbiopara.2015.11.003","article-title":"Thiol redox biology of trypanosomatids and potential targets for chemotherapy","volume":"206","author":"Leroux","year":"2016","journal-title":"Mol. Biochem. Parasitol."},{"issue":"2","key":"10.1016\/j.ejmech.2018.08.012_bib25","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s002329900349","article-title":"Conformational analysis of amphotericin B\u2014cholesterol channel complex","volume":"162","author":"Silberstein","year":"1998","journal-title":"J.\u00a0Membr. Biol."},{"issue":"10","key":"10.1016\/j.ejmech.2018.08.012_bib26","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/00001813-200011000-00006","article-title":"Phase II study of miltefosine 6% solution as topical treatment of skin metastases in breast cancer patients","volume":"11","author":"Smorenburg","year":"2000","journal-title":"Anti Canc. Drugs"},{"key":"10.1016\/j.ejmech.2018.08.012_bib27","series-title":"Platelet-activating Factor and Related Lipid Mediators 2","first-page":"201","article-title":"Ether lipid metabolism, GPI anchor biosynthesis, and signal transduction are putative targets for anti-leishmanial alkyl phospholipid analogues","author":"Lux","year":"1996"},{"issue":"2","key":"10.1016\/j.ejmech.2018.08.012_bib28","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1097\/00001813-200302000-00011","article-title":"Anti-cancer alkyl-lysophospholipids inhibit the phosphatidylinositol 3-kinase\u2013Akt\/PKB survival pathway","volume":"14","author":"Ruiter","year":"2003","journal-title":"Anti Canc. Drugs"},{"issue":"11","key":"10.1016\/j.ejmech.2018.08.012_bib29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pt.2003.09.003","article-title":"Therapy of intestinal protozoa","volume":"19","author":"Petri","year":"2003","journal-title":"Trends Parasitol."},{"issue":"1","key":"10.1016\/j.ejmech.2018.08.012_bib30","first-page":"90","article-title":"Comparative study of the chemotherapeutic effect of paromomycin and monomycin in experimental cutaneous leischmaniasis in albino mice","volume":"29","author":"NIu","year":"1966","journal-title":"Farmakologiia i toksikologiia"},{"issue":"2","key":"10.1016\/j.ejmech.2018.08.012_bib31","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1006\/excr.1997.3500","article-title":"In VivoInterference of paromomycin with mitochondrial activity ofLeishmania","volume":"232","author":"Maarouf","year":"1997","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.ejmech.2018.08.012_bib32","first-page":"82","article-title":"Sulla terapia della leishmaniosi interna","volume":"7","author":"Di Cristina","year":"1915","journal-title":"Pathologica"},{"issue":"5","key":"10.1016\/j.ejmech.2018.08.012_bib33","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1179\/joc.2001.13.5.461","article-title":"Renal transport of antibiotics and nephrotoxicity: a review","volume":"13","author":"Fanos","year":"2001","journal-title":"J.\u00a0Chemother."},{"issue":"3","key":"10.1016\/j.ejmech.2018.08.012_bib34","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1086\/514704","article-title":"Lipid formulations of amphotericin B: clinical efficacy and toxicities","volume":"27","author":"Wong-Beringer","year":"1998","journal-title":"Clin. Infect. Dis."},{"issue":"4","key":"10.1016\/j.ejmech.2018.08.012_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/cid\/cis474","article-title":"Efficacy of miltefosine in the treatment of visceral leishmaniasis in India after a decade of use","volume":"55","author":"Sundar","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.ejmech.2018.08.012_bib36","series-title":"Substituted Benzamidines as Antibacterial Agents","author":"Haydon","year":"2013"},{"issue":"4","key":"10.1016\/j.ejmech.2018.08.012_bib37","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1128\/AAC.7.4.426","article-title":"Mechanism of action of anti-influenza benzamidine derivatives","volume":"7","author":"Fujita","year":"1975","journal-title":"Antimicrob. Agents Chemother."},{"issue":"12","key":"10.1016\/j.ejmech.2018.08.012_bib38","first-page":"941","article-title":"N-acyl-N'-methyl-N-(1, 3, 3-trimethylbicyclo [2.2. 1] hept-2-yl) benzamidines with hypotensive activity","volume":"42","author":"Bondavalli","year":"1987","journal-title":"Il Farmaco; edizione scientifica"},{"issue":"12","key":"10.1016\/j.ejmech.2018.08.012_bib39","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1021\/ja01180a033","article-title":"Methoxysubstituted benzamidines as local anesthetics","volume":"71","author":"Sintov","year":"1949","journal-title":"J.\u00a0Am. Chem. Soc."},{"key":"10.1016\/j.ejmech.2018.08.012_bib40","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.ejmech.2013.06.040","article-title":"Synthesis, antileishmanial activity and structure\u2013activity relationship of 1-N-X-phenyl-3-N\u2032-Y-phenyl-benzamidines","volume":"67","author":"Rodrigues-Santos","year":"2013","journal-title":"Eur. J. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejmech.2018.08.012_bib41","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0928-0987(99)00038-X","article-title":"Synthesis, antibacterial, antifungal and anti-HIV activities of Schiff and Mannich bases derived from isatin derivatives and N-[4-(4\u2032-chlorophenyl) thiazol-2-yl] thiosemicarbazide","volume":"9","author":"Pandeya","year":"1999","journal-title":"Eur. J. Pharmaceut. Sci."},{"issue":"22","key":"10.1016\/j.ejmech.2018.08.012_bib42","doi-asserted-by":"crossref","first-page":"7482","DOI":"10.1016\/j.bmc.2006.07.015","article-title":"Synthesis and biological activity of Schiff and Mannich bases bearing 2, 4-dichloro-5-fluorophenyl moiety","volume":"14","author":"Karthikeyan","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"22","key":"10.1016\/j.ejmech.2018.08.012_bib43","doi-asserted-by":"crossref","first-page":"7795","DOI":"10.1016\/j.bmc.2009.09.028","article-title":"Synthesis of bis-Schiff bases of isatins and their antiglycation activity","volume":"17","author":"Khan","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"8","key":"10.1016\/j.ejmech.2018.08.012_bib44","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1016\/j.bmc.2009.03.020","article-title":"Schiff bases of 3-formylchromone as thymidine phosphorylase inhibitors","volume":"17","author":"Khan","year":"2009","journal-title":"Bioorg. Med. Chem."},{"issue":"11","key":"10.1016\/j.ejmech.2018.08.012_bib45","doi-asserted-by":"crossref","first-page":"3463","DOI":"10.1016\/j.bmcl.2013.03.051","article-title":"Synthesis of 2-methoxybenzoylhydrazone and evaluation of their antileishmanial activity","volume":"23","author":"Taha","year":"2013","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5","key":"10.1016\/j.ejmech.2018.08.012_bib46","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1515\/HC.2009.15.5.355","article-title":"Synthesis and antitumor activity evaluation of regioselective spiro [pyrrolidine-2, 3'-oxindole] compounds","volume":"15","author":"Chen","year":"2009","journal-title":"Heterocycl. Commun."},{"issue":"2","key":"10.1016\/j.ejmech.2018.08.012_bib47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S0960-894X(97)10206-2","article-title":"Quaternary substituted PDE4 inhibitors I: the synthesis and in\u00a0vitro evaluation of a novel series of oxindoles","volume":"8","author":"Hulme","year":"1998","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"14","key":"10.1016\/j.ejmech.2018.08.012_bib48","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1021\/jm980123i","article-title":"Synthesis and biological evaluations of 3-substituted indolin-2-ones: a novel class of tyrosine kinase inhibitors that exhibit selectivity toward particular receptor tyrosine kinases","volume":"41","author":"Sun","year":"1998","journal-title":"J.\u00a0Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2018.08.012_bib49","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.bmc.2013.12.039","article-title":"Direct synthesis of C3-mono-functionalized oxindoles from N-unprotected 2-oxindole and their antileishmanial activity","volume":"22","author":"Scala","year":"2014","journal-title":"Bioorg. Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2018.08.012_bib50","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.bmcl.2018.02.023","article-title":"Synthesis and biological evaluation of polyhydroxylated oxindole derivatives as potential antileishmanial agent","volume":"28","author":"Yousuf","year":"2018","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2018.08.012_bib51","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1211\/0022357001773814","article-title":"Synthesis and anti-inflammatory effect of chalcones","volume":"52","author":"HSIEH","year":"2000","journal-title":"J.\u00a0Pharm. Pharmacol."},{"issue":"22","key":"10.1016\/j.ejmech.2018.08.012_bib52","doi-asserted-by":"crossref","first-page":"9790","DOI":"10.1016\/j.bmc.2008.09.064","article-title":"Structure\u2013activity relationship of antibacterial chalcones","volume":"16","author":"\u00c1vila","year":"2008","journal-title":"Bioorg. Med. Chem."},{"issue":"48","key":"10.1016\/j.ejmech.2018.08.012_bib53","doi-asserted-by":"crossref","first-page":"8472","DOI":"10.1016\/j.tetlet.2007.09.175","article-title":"Improved and rapid synthesis of new coumarinyl chalcone derivatives and their antiviral activity","volume":"48","author":"Trivedi","year":"2007","journal-title":"Tetrahedron Letters"},{"issue":"26","key":"10.1016\/j.ejmech.2018.08.012_bib54","doi-asserted-by":"crossref","first-page":"5031","DOI":"10.1021\/jm00026a010","article-title":"In\u00a0vitro antimalarial activity of chalcones and their derivatives","volume":"38","author":"Li","year":"1995","journal-title":"J.\u00a0Med. Chem."},{"issue":"10","key":"10.1016\/j.ejmech.2018.08.012_bib55","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1016\/S0960-894X(03)00197-5","article-title":"Anti-AIDS agents 54. A potent anti-HIV chalcone and flavonoids from genus Desmos","volume":"13","author":"Wu","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.012_bib56","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.ejmech.2014.05.034","article-title":"Synthesis and biological evaluation of chalcones as potential antileishmanial agents","volume":"81","author":"Gupta","year":"2014","journal-title":"Eur. J. Med. Chem."},{"issue":"15","key":"10.1016\/j.ejmech.2018.08.012_bib57","doi-asserted-by":"crossref","first-page":"3247","DOI":"10.1016\/j.bmcl.2014.06.030","article-title":"Synthesis, antileishmanial and antitrypanosomal activities of N-substituted tetrahydro-\u03b2-carbolines","volume":"24","author":"Manda","year":"2014","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"4","key":"10.1016\/j.ejmech.2018.08.012_bib58","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1016\/j.ejmech.2007.06.010","article-title":"Synthesis of novel 4, 6-disubstituted quinazoline derivatives, their anti-inflammatory and anti-cancer activity (cytotoxic) against U937 leukemia cell lines","volume":"43","author":"Chandrika","year":"2008","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.012_bib59","series-title":"Synthesis of N-3 (4-(4-chlorophenyl Thiazole-2-yl)-(2-(amino) Methyl)-quinazoline-4 (3H)-one and Their Derivatives for Antitubercular Activity","author":"Pattan","year":"2006"},{"issue":"22","key":"10.1016\/j.ejmech.2018.08.012_bib60","doi-asserted-by":"crossref","first-page":"4705","DOI":"10.1021\/jm9903500","article-title":"Structure\u2212 activity relationships of novel 2-substituted quinazoline antibacterial agents","volume":"42","author":"Kung","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2018.08.012_bib61","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.1016\/j.bmcl.2009.03.020","article-title":"Synthesis and biological evaluation of novel 4-(hetero) aryl-2-piperazino quinazolines as anti-leishmanial and anti-proliferative agents","volume":"19","author":"Kumar","year":"2009","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"12","key":"10.1016\/j.ejmech.2018.08.012_bib62","doi-asserted-by":"crossref","first-page":"5141","DOI":"10.1021\/jm5000408","article-title":"Antileishmanial activity of a series of N 2, N 4-disubstituted quinazoline-2, 4-diamines","volume":"57","author":"Van Horn","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.012_bib63","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1002\/cmdc.201800119","article-title":"The current status of O-Heterocycles: a synthetic and medicinal overview","volume":"13","author":"Singh","year":"2018","journal-title":"ChemMedChem"},{"issue":"22","key":"10.1016\/j.ejmech.2018.08.012_bib64","doi-asserted-by":"crossref","first-page":"3673","DOI":"10.1021\/jm0101693","article-title":"Investigation of 5-nitrofuran derivatives: synthesis, antibacterial activity, and quantitative Structure\u2212 activity relationships","volume":"44","author":"Pires","year":"2001","journal-title":"J.\u00a0Med. Chem."},{"issue":"6","key":"10.1016\/j.ejmech.2018.08.012_bib65","doi-asserted-by":"crossref","first-page":"2602","DOI":"10.1016\/j.ejmech.2011.03.053","article-title":"Synthesis and antileishmanial activity of novel 5-(5-nitrofuran-2-y1)-1, 3, 4-thiadiazoles with piperazinyl-linked benzamidine substituents","volume":"46","author":"Tahghighi","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.012_bib66","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.ejmech.2012.01.046","article-title":"Synthesis and anti-leishmanial activity of 5-(5-nitrofuran-2-yl)-1, 3, 4-thiadiazol-2-amines containing N-[(1-benzyl-1H-1, 2, 3-triazol-4-yl) methyl] moieties","volume":"50","author":"Tahghighi","year":"2012","journal-title":"Eur. J. Med. Chem."},{"issue":"2","key":"10.1016\/j.ejmech.2018.08.012_bib67","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00044-014-1155-1","article-title":"Synthesis, antileishmanial activity and QSAR study of (1, 3, 4-thiadiazol-2-ylthio) acetamides derived from 5-nitrofuran","volume":"24","author":"Vosooghi","year":"2015","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2018.08.012_bib68","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/j.ejmech.2012.10.048","article-title":"Synthesis and biological evaluation of 2, 3-diarylimidazo [1, 2-a] pyridines as antileishmanial agents","volume":"58","author":"Marhadour","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.012_bib69","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1016\/j.ejmech.2015.09.002","article-title":"Synthesis, antileishmanial activity and cytotoxicity of 2, 3-diaryl-and 2, 3, 8-trisubstituted imidazo [1, 2-a] pyrazines","volume":"103","author":"Marchand","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"4","key":"10.1016\/j.ejmech.2018.08.012_bib70","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.bmc.2004.11.016","article-title":"QSAR studies on some thiophene analogs as anti-inflammatory agents: enhancement of activity by electronic parameters and its utilization for chemical lead optimization","volume":"13","author":"Pillai","year":"2005","journal-title":"Bioorg. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2018.08.012_bib71","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1021\/jm00171a048","article-title":"Heterosubstituted anthracene-9, 10-dione analogs. The synthesis and antitumor evaluation of 5, 8-bis [(aminoalkyl) amino] naphtho [2, 3-b] thiophene-4, 9-diones","volume":"33","author":"Krapcho","year":"1990","journal-title":"J.\u00a0Med. Chem."},{"issue":"19","key":"10.1016\/j.ejmech.2018.08.012_bib72","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1016\/j.lfs.2004.10.038","article-title":"Antinociceptive properties of acetylenic thiophene and furan derivatives: evidence for the mechanism of action","volume":"76","author":"Goncales","year":"2005","journal-title":"Life Sciences"},{"issue":"10","key":"10.1016\/j.ejmech.2018.08.012_bib73","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00706-003-0051-z","article-title":"Synthesis and reactions of some fused oxazinone, pyrimidinone, thiopyrimidinone, and triazinone derivatives with a thiophene ring as analgesic, anticonvulsant, and antiparkinsonian agents","volume":"134","author":"Amr","year":"2003","journal-title":"Monatshefte f\u00fcr Chemie\/Chemical Monthly"},{"issue":"12","key":"10.1016\/j.ejmech.2018.08.012_bib74","doi-asserted-by":"crossref","first-page":"5935","DOI":"10.1016\/j.ejmech.2010.09.059","article-title":"Antiarrhythmic, serotonin antagonist and antianxiety activities of novel substituted thiophene derivatives synthesized from 2-amino-4, 5, 6, 7-tetrahydro-N-phenylbenzo [b] thiophene-3-carboxamide","volume":"45","author":"Amr","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2018.08.012_bib75","doi-asserted-by":"crossref","first-page":"3692","DOI":"10.1016\/j.ejmech.2010.05.018","article-title":"Synthesis and antimicrobial activity of some new thiazole, thiophene and pyrazole derivatives containing benzothiazole moiety","volume":"45","author":"Bondock","year":"2010","journal-title":"Eur. J. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejmech.2018.08.012_bib76","doi-asserted-by":"crossref","first-page":"3469","DOI":"10.3390\/molecules16053469","article-title":"Thiophene derivatives with antileishmanial activity isolated from aerial parts of Porophyllum ruderale (Jacq.) Cass","volume":"16","author":"Takahashi","year":"2011","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2018.08.012_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejmech.2015.10.011","article-title":"2-Amino-thiophene derivatives present antileishmanial activity mediated by apoptosis and immunomodulation in\u00a0vitro","volume":"106","author":"da Franca Rodrigues","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"9","key":"10.1016\/j.ejmech.2018.08.012_bib78","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1016\/j.bmcl.2015.03.027","article-title":"Synthesis and biological evaluation of 2-arylbenzimidazoles targeting Leishmania donovani","volume":"25","author":"Keurulainen","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"5\u20136","key":"10.1016\/j.ejmech.2018.08.012_bib79","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0166-3542(87)80004-9","article-title":"Antiviral activity of phosphonylmethoxyalkyl derivatives of purine and pyrimidines","volume":"8","author":"De Clercq","year":"1987","journal-title":"Antivir. Res."},{"issue":"1","key":"10.1016\/j.ejmech.2018.08.012_bib80","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1021\/jm00235a017","article-title":"Pyrido [2, 3-d] pyrimidine antibacterial agents. 3. 8-alkyl-and 8-vinyl-5, 8-dihydro-5-oxo-2-(1-piperazinyl) pyrido [2, 3-d] pyrimidine-6-carboxylic acids and their derivatives","volume":"18","author":"Matsumoto","year":"1975","journal-title":"J.\u00a0Med. Chem."},{"issue":"26","key":"10.1016\/j.ejmech.2018.08.012_bib81","doi-asserted-by":"crossref","first-page":"9938","DOI":"10.1021\/jo030248h","article-title":"A\u00a0new and efficient synthesis of pyrrolo [2, 3-d] pyrimidine anticancer agents: alimta (LY231514, MTA), homo-alimta, TNP-351, and some aryl 5-substituted pyrrolo [2, 3-d] pyrimidines","volume":"68","author":"Taylor","year":"2003","journal-title":"J.\u00a0Org. Chem."},{"issue":"23","key":"10.1016\/j.ejmech.2018.08.012_bib82","doi-asserted-by":"crossref","first-page":"7706","DOI":"10.1016\/j.bmc.2006.08.009","article-title":"Synthesis of 2, 4, 6-trisubstituted pyrimidine and triazine heterocycles as antileishmanial agents","volume":"14","author":"Sunduru","year":"2006","journal-title":"Bioorg. Med. Chem."},{"issue":"13","key":"10.1016\/j.ejmech.2018.08.012_bib83","doi-asserted-by":"crossref","first-page":"2617","DOI":"10.1016\/j.bmcl.2015.04.097","article-title":"Synthesis of 5-isoxazol-3-yl-pyrimidine nucleosides as potential antileishmanial agents","volume":"25","author":"Guo","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"issue":"2","key":"10.1016\/j.ejmech.2018.08.012_bib84","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1016\/j.bmcl.2014.09.078","article-title":"Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents","volume":"25","author":"Tiwari","year":"2015","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.08.012_bib85","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2015.02.038","article-title":"New heterocyclic hybrids of pyrazole and its bioisosteres: design, synthesis and biological evaluation as dual acting antimalarial-antileishmanial agents","volume":"94","author":"Bekhit","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.012_bib86","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.saa.2014.11.061","article-title":"Synthesis, spectroscopic characterization and in\u00a0vitro antimicrobial, anticancer and antileishmanial activities as well interaction with Salmon sperm DNA of newly synthesized carboxylic acid derivative, 4-(4-methoxy-2-nitrophenylamino)-4-oxobutanoic acid","volume":"138","author":"Sirajuddin","year":"2015","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.ejmech.2018.08.012_bib87","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.ejmech.2015.02.046","article-title":"Synthesis, characterization, and antileishmanial activities of gold (I) complexes involving quinoline functionalized N-heterocyclic carbenes","volume":"94","author":"Paloque","year":"2015","journal-title":"Eur. J. Med. Chem."},{"issue":"3","key":"10.1016\/j.ejmech.2018.08.012_bib88","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1002\/cmdc.201402537","article-title":"Synthesis and biological evaluation of ferrocenylquinoline as a potential antileishmanial agent","volume":"10","author":"Yousuf","year":"2015","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.08.012_bib89","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.ejmech.2016.08.049","article-title":"Antileishmanial ferrocenylquinoline derivatives: synthesis and biological evaluation against Leishmania donovani","volume":"124","author":"Yousuf","year":"2016","journal-title":"Eur. J. Med. Chem."},{"issue":"7","key":"10.1016\/j.ejmech.2018.08.012_bib90","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/cmdc.201700770","article-title":"1, 3, 5-triazino peptide derivatives: synthesis, characterization, and preliminary antileishmanial activity","volume":"13","author":"Khattab","year":"2018","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ejmech.2018.08.012_bib91","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.ejmech.2017.08.055","article-title":"Efficacy of a series of alpha-pyrone derivatives against Leishmania (L.) infantum and Trypanosoma cruzi","volume":"139","author":"Tempone","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.08.012_bib92","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ejmech.2017.04.020","article-title":"First example of peptides targeting the dimer interface of Leishmania infantum trypanothione reductase with potent in\u00a0vitro antileishmanial activity","volume":"135","author":"Ruiz-Santaquiteria","year":"2017","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418306706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418306706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T13:48:47Z","timestamp":1759326527000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418306706"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":92,"alternative-id":["S0223523418306706"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.012","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An update on small molecule strategies targeting leishmaniasis","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.08.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}